Recombinant human interleukin-1 (IL-1) alpha and beta were found to ac
tivate a latent cytosolic form of the transcription factor NFkappaB in
rat C6 glioma. IL-1beta was 10 times more potent than IL-1 alpha for
this activity and both were inhibited by the IL-1 receptor antagonist.
The activation was detectable from 20 min and remained sustained for
up to 24 h. The electrophoretic mobility of the activated complex was
shown to be different from that of the corresponding complexes in anot
her IL-1-responsive cell line, the murine thymoma line EL4.NOB-1. C6 c
ells, when transiently transfected with five NFkappaB consensus sequen
ce repeats linked to the reporter gene chloramphenicol acetyltransfera
se (CAT), demonstrated increased CAT activity in response to IL-1beta
treatment. The activation of NFkappaB in glial cells may thus represen
t an early step in IL-1 signalling in brain and is likely to have cons
equences for IL-1-induced gene expression in these cells.